CSF2 and urogenital neoplasm: The autologous DCs in sipuleucel-T were activated using a recombinant fusion protein containing prostatic acid phosphatase (PAP, a prostate TAA) and granulocyte-macrophage colony-stimulating factor (GM-CSF).